KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $143,592,000 | +83.4% | 798,569 | +5.8% | 0.07% | +72.5% |
Q2 2017 | $78,276,000 | +8.7% | 755,069 | -17.7% | 0.04% | +2.6% |
Q1 2017 | $72,039,000 | +120.4% | 917,818 | +25.9% | 0.04% | +116.7% |
Q4 2016 | $32,690,000 | -9.5% | 729,040 | +12.8% | 0.02% | -10.0% |
Q3 2016 | $36,108,000 | +331.9% | 646,391 | +286.6% | 0.02% | +300.0% |
Q2 2016 | $8,360,000 | -3.6% | 167,206 | -11.5% | 0.01% | 0.0% |
Q1 2016 | $8,672,000 | -24.9% | 188,897 | +0.8% | 0.01% | -37.5% |
Q4 2015 | $11,548,000 | +2286.0% | 187,406 | +2056.8% | 0.01% | – |
Q3 2015 | $484,000 | -45.2% | 8,689 | -40.1% | 0.00% | -100.0% |
Q2 2015 | $884,000 | +163.1% | 14,500 | +148.9% | 0.00% | – |
Q1 2015 | $336,000 | -61.1% | 5,825 | -61.1% | 0.00% | -100.0% |
Q4 2014 | $864,000 | +5.2% | 14,991 | -47.9% | 0.00% | 0.0% |
Q3 2014 | $821,000 | – | 28,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |